Terms: = Prostate cancer AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R AND Treatment
3 results:
1. Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.
Qi C; Bin Li ; Yang Y; Yang Y; Li J; Zhou Q; Wen Y; Zeng C; Zheng L; Zhang Q; Li J; He X; Zhou J; Shao C; Wang L
Sci Rep; 2016 Jun; 6():27819. PubMed ID: 27292155
[TBL] [Abstract] [Full Text] [Related]
2. Downregulation of miR-195 promotes prostate cancer progression by targeting hmga1.
Zhang X; Tao T; Liu C; Guan H; Huang Y; Xu B; Chen M
Oncol Rep; 2016 Jul; 36(1):376-82. PubMed ID: 27175617
[TBL] [Abstract] [Full Text] [Related]
3. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M
Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648
[TBL] [Abstract] [Full Text] [Related]
